Global and United States in Vitro Diagnostics (ivd) Market Report & Forecast 2023-2029

Report ID: ARS3073 | Category: Agriculture | Pages: 113 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4350.00 Multi User-$6300.00

Report Description
View Table of Contents

Report Summary

The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global in Vitro Diagnostics (ivd) Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global in Vitro Diagnostics (ivd) market size in 2022 is 112640.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the in Vitro Diagnostics (ivd) market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), and Thermo Fisher Scientific (US). The share of the top 3 players in the in Vitro Diagnostics (ivd) market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of in Vitro Diagnostics (ivd) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Reagents & Kits accounted for XX% of in Vitro Diagnostics (ivd) market in 2022. Instruments share of XX%.
Immunoassay/ Immunochemistry accounted for XX% of the in Vitro Diagnostics (ivd) market in 2022. Clinical Chemistry accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Digital technology is becoming more and more popular in agricultural value chain
Digital technology is becoming more and more popular in agricultural value chain, which reduces information asymmetry, improves transparency and raises output to a new high. So far, agricultural technology has promoted the development of agriculture in four "times" and continues to determine the maturity of producing countries. 
For example, in terms of corn production, Africa and India are still in the first stage, known as the Green Revolution, which is characterized by the use of fertilizers and pesticides. Argentina, Brazil and China are in the stage of modern agriculture, which involves a new generation of crop protection products and new farming methods, such as mechanization. The European Union and the United States have developed into the 21st century agriculture characterized by precision agriculture-for example, using advanced analytical techniques to apply nutrients and crop protection products in different proportions.
In the next few years, only the producers who master precision agriculture can be ready to use the fourth era, that is, the next generation of agricultural technology. Although it is still far away, this era will be characterized by the the proliferation of biotechnologies, gene editing (such as CRISPR), and automation, including agricultural robots that will monitor fields and harvest crops.

Highlights-Regions

North America
   United States
   Canada
Europe
   Germany
   France
   UK
   Italy
   Russia
 Asia Pacific
   China
   Japan
   South Korea
   India
   Southeast Asia
   Australia
Latin America
   Brazil
   Argentina
   Mexico
MEA
   Saudi Arabia
   UAE
   Turkey

Player list
	Roche Diagnostics (Switzerland)
	Siemens Healthineers (Germany)
	Danaher Corporation (US)
	Abbott (US)
	Thermo Fisher Scientific (US)
	Johnson & Johnson (US)
	Becton Dickinson & Company (US)
	Bio-Rad Laboratories (US)
	Sysmex Corporation (Japan)
	bioMérieux (France)
	DiaSorin (Italy)
	Ortho Clinical Diagnostics (US)
	QIAGEN N.V. (Netherlands)

Types list
	Reagents & Kits
	Instruments
	Services
	Data Management Software

Application list
	Immunoassay/ Immunochemistry
	Clinical Chemistry
	Molecular Diagnostics
	Hematology
	Microbiology
	Coagulation & Hemostasis
	Urinalysis
	Other Technologies

Table of Content

1 Study Coverage
1.1 in Vitro Diagnostics (ivd) Product Introduction
1.2 Global in Vitro Diagnostics (ivd) Outlook 2018 VS 2023 VS 2029
1.3 United States in Vitro Diagnostics (ivd) Outlook 2018 VS 2023 VS 2029
1.4 in Vitro Diagnostics (ivd) Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States in Vitro Diagnostics (ivd) in Global, 2018-2029
1.4.2 The Growth Rate of in Vitro Diagnostics (ivd) Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 in Vitro Diagnostics (ivd) Market Dynamics
1.5.1 in Vitro Diagnostics (ivd) Market Trends
1.5.2 in Vitro Diagnostics (ivd) Market Drivers
1.5.3 in Vitro Diagnostics (ivd) Market Challenges
1.5.4 in Vitro Diagnostics (ivd) Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global in Vitro Diagnostics (ivd) Competitor Landscape by Company
2.1 Global in Vitro Diagnostics (ivd) Market Size by Company
2.1.1 Top Global in Vitro Diagnostics (ivd) Player Ranked by Revenue (2023)
2.1.2 Global in Vitro Diagnostics (ivd) Revenue by Player (2018-2023)
2.2 Global in Vitro Diagnostics (ivd) Concentration Ratio (CR)
2.2.1 in Vitro Diagnostics (ivd) Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of in Vitro Diagnostics (ivd) in 2023
2.3 Global in Vitro Diagnostics (ivd) Business Distribution, Business Type
2.3.1 Global in Vitro Diagnostics (ivd) Players, Headquarters and Distribution
2.3.2 Players in Vitro Diagnostics (ivd) Business Type
2.3.3 Date of International Players Enter into in Vitro Diagnostics (ivd) Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States in Vitro Diagnostics (ivd) Market Size by Company
2.5.1 Top United States in Vitro Diagnostics (ivd) Player s Ranked by Revenue (2023)
2.5.2 United States in Vitro Diagnostics (ivd) Revenue by Player (2018-2023)
3 in Vitro Diagnostics (ivd) Market Segment by Type
3.1 in Vitro Diagnostics (ivd) Market Segment by Type
3.2 Global in Vitro Diagnostics (ivd) Market Size by Type
3.3 United States in Vitro Diagnostics (ivd) Market Size by Type
4 in Vitro Diagnostics (ivd) by Market Segment Application
4.1 in Vitro Diagnostics (ivd) Market Segment by Application
4.2 Global in Vitro Diagnostics (ivd) Market Size by Application
4.3 United States in Vitro Diagnostics (ivd) Market Size by Application
5 Global in Vitro Diagnostics (ivd) Market Size by Region
5.1 Global in Vitro Diagnostics (ivd) Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global in Vitro Diagnostics (ivd) Market Size in Value by Region (2018-2029)
5.2.1 Global in Vitro Diagnostics (ivd) Revenue by Region: 2018-2023
5.2.2 Global in Vitro Diagnostics (ivd) Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America in Vitro Diagnostics (ivd) Market Size YoY Growth 2018-2029
6.1.2 North America in Vitro Diagnostics (ivd) Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific in Vitro Diagnostics (ivd) Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific in Vitro Diagnostics (ivd) Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe in Vitro Diagnostics (ivd) Market Size YoY Growth 2018-2029
6.3.2 Europe in Vitro Diagnostics (ivd) Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America in Vitro Diagnostics (ivd) Market Size YoY Growth 2018-2029
6.4.2 Latin America in Vitro Diagnostics (ivd) Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa in Vitro Diagnostics (ivd) Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa in Vitro Diagnostics (ivd) Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1  Roche Diagnostics (Switzerland)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 in Vitro Diagnostics (ivd) Introduction
7.1.4 Roche Diagnostics (Switzerland) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 Roche Diagnostics (Switzerland) Recent Development
7.2  Siemens Healthineers (Germany)
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 in Vitro Diagnostics (ivd) Introduction
7.2.4 Siemens Healthineers (Germany) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 Siemens Healthineers (Germany) Recent Development
7.3  Danaher Corporation (US)
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 in Vitro Diagnostics (ivd) Introduction
7.3.4 Danaher Corporation (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 Danaher Corporation (US) Recent Development
7.4  Abbott (US)
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 in Vitro Diagnostics (ivd) Introduction
7.4.4 Abbott (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 Abbott (US) Recent Development
7.5  Thermo Fisher Scientific (US)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 in Vitro Diagnostics (ivd) Introduction
7.5.4 Thermo Fisher Scientific (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 Thermo Fisher Scientific (US) Recent Development
7.6  Johnson & Johnson (US)
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 in Vitro Diagnostics (ivd) Introduction
7.6.4 Johnson & Johnson (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Johnson & Johnson (US) Recent Development
7.7  Becton Dickinson & Company (US)
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 in Vitro Diagnostics (ivd) Introduction
7.7.4 Becton Dickinson & Company (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.7.5 Becton Dickinson & Company (US) Recent Development
7.8  Bio-Rad Laboratories (US)
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 in Vitro Diagnostics (ivd) Introduction
7.8.4 Bio-Rad Laboratories (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.8.5 Bio-Rad Laboratories (US) Recent Development
7.9  Sysmex Corporation (Japan)
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 in Vitro Diagnostics (ivd) Introduction
7.9.4 Sysmex Corporation (Japan) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.9.5 Sysmex Corporation (Japan) Recent Development
7.10  bioMérieux (France)
7.10.1 Company Details
7.10.2 Description and Business Overview
7.10.3 in Vitro Diagnostics (ivd) Introduction
7.10.4 bioMérieux (France) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.10.5 bioMérieux (France) Recent Development
7.11  DiaSorin (Italy)
7.11.1 Company Details
7.11.2 Description and Business Overview
7.11.3 in Vitro Diagnostics (ivd) Introduction
7.11.4 DiaSorin (Italy) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.11.5 DiaSorin (Italy) Recent Development
7.12  Ortho Clinical Diagnostics (US)
7.12.1 Company Details
7.12.2 Description and Business Overview
7.12.3 in Vitro Diagnostics (ivd) Introduction
7.12.4 Ortho Clinical Diagnostics (US) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.12.5 Ortho Clinical Diagnostics (US) Recent Development
7.13  QIAGEN N.V. (Netherlands)
7.13.1 Company Details
7.13.2 Description and Business Overview
7.13.3 in Vitro Diagnostics (ivd) Introduction
7.13.4 QIAGEN N.V. (Netherlands) in Vitro Diagnostics (ivd) Revenue, Gross, and Gross Margin (2018-2023)
7.13.5 QIAGEN N.V. (Netherlands) Recent Development
8 Value Chain and Sales Channels Analysis
8.1 in Vitro Diagnostics (ivd) Value Chain Analysis
8.2 in Vitro Diagnostics (ivd) Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and United States in Vitro Diagnostics (ivd) Market Report & Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?